Mediators of Inflammation

Table of Contents: 1996

  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 975014

Plasma levels of immunosuppressive mediators during cardiopulmonary bypass

E. Borrelli | P. Giomarelli | ... | V. Bocci
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 210240

Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein

J.-O. Häggblom | A. B. Jokilammi-Siltanen | ... | T. J. Nevalainen
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 917478

Serum levels of total IgE and soluble CD23 in bronchial asthma

G. Di Lorenzo | P. Mansueto | ... | C. Caruso
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 643741

The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release

G. S. Smith | C. Rieckenberg | ... | T. A. Miller
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 196865

Leukotriene C4 biosynthesis in isolated August rat peritoneal leukocytes

J. M. Huebner | R. R. Eversole | ... | L. J. Beuving
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 953147

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes

E. Robak | A. Sysa-Jędrzejowska | ... | E. Waszczykowsk
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 682178

Role of transforming growth factor-β1 in down-regulating TNF production by alveolar macrophages during asbestos-induced pulmonary fibrosis

Irma Lemaire | Sophie Ouellet
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 318056

Changes in TNF and IL-6 production after diphtheria toxoid vaccination: drug modulation of the cytokine levels

A. L. Pukhalsky | M. S. Bliacher | ... | I. M. Fedorova
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 129686

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-α release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors

A. Hichami | E. Boichot | ... | V. Lagente
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 845412

Cytokines as cellular communicators

R. Debets | H. F. J. Savelkoul
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 243174

Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy?

F. A. A. van Acker | H-P. Voss | H. Timmerman
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 174128

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation

N. Ringdal | P. Swinburn | ... | T. A. J. Harris
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 578521

Apoptotic cell death, detected ex vivo in peripheral blood lymphocytes of HIV-1 infected persons

L. F. te Velde | I. Vermes | ... | C. H. H. ten Napel
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 732614

Induction of annexin-1 at transcriptional and post-transcriptional level in rat brain by methylprednisolone and the 21-aminosteroid U74389F

P. H. Voermans | K. G. Go | ... | L. Parente
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 734054

Cell surface antigen expression by peripheral blood monocytes in allergic asthma: results of 2.5 years therapy with inhaled beclomethasone dipropionate

W. A. T. Slieker | P. Th. W. van Hal | ... | H. C. Hoogsteden
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.